Patent details

300124 Product Name: Tadalafil, evenals de fysiologisch aanvaardbare zouten en solvaten daarvan.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300124
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0740668
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300124
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

1

Marketing Authorization Number:
EU/1/02/237/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
14/11/2002
Marketing Authorization Country:
European Union (EU)

2

Marketing Authorization Number:
EU/1/02/237/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
14/11/2002
Marketing Authorization Country:
European Union (EU)

3

Marketing Authorization Number:
EU/1/02/237/003
Marketing Authorization Type:
EEA
Marketing Authorization Date:
14/11/2002
Marketing Authorization Country:
European Union (EU)

4

Marketing Authorization Number:
EU/1/02/237/004
Marketing Authorization Type:
EEA
Marketing Authorization Date:
14/11/2002
Marketing Authorization Country:
European Union (EU)

5

Marketing Authorization Number:
EU/1/02/237/001
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
14/11/2002
Marketing Authorization Country:
Netherlands (NL)

6

Marketing Authorization Number:
EU/1/02/237/002
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
14/11/2002
Marketing Authorization Country:
Netherlands (NL)

7

Marketing Authorization Number:
EU/1/02/237/003
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
14/11/2002
Marketing Authorization Country:
Netherlands (NL)

8

Marketing Authorization Number:
EU/1/02/237/004
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
14/11/2002
Marketing Authorization Country:
Netherlands (NL)

Dates

Filing date:
23/04/2003
First Marketing Authorization date:
14/11/2002
Grant date:
10/09/2003
Activation date:
19/01/2015
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
23/04/2003
SPC/SPC Extension Expiration Date:
13/11/2017
Lapsed By Expiration Date:
14/11/2017
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
23/04/2003
 
 

 

Name:
ICOS CORPORATION
Address:
22021 20th Avenue, S.E., 98201, Bothell, Washington, United States of America (US)

Agent

Name:
ir. A. Blokland c.s.
From:
23/04/2003
Address:
Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
46/17
Publication date:
15/11/2017
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
2015/05
Publication date:
28/01/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
2003/11
Publication date:
03/11/2003
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
2003/07
Publication date:
01/07/2003
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
09/01/2017
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
28/06/2016 SPC Documents Subsequently filed documents 1 PDF /4/2/1/0/0/0400300124/docs/300124_8_supplprotectioncertificate20160630101313765.pdf
28/06/2016 Outgoing Correspondence Outgoing Letter 1 PDF /4/2/1/0/0/0400300124/docs/300124_11_outgoingcorrespondence20160630101313668.pdf
28/06/2016 Outgoing Correspondence Outgoing Letter 1 PDF /4/2/1/0/0/0400300124/docs/300124_14_65330l504a.pdf
27/05/2016 SPC Documents Marketing Authorization SPC 1 PDF /4/2/1/0/0/0400300124/docs/300124_12_supplprotectioncertificate20160527025112507.pdf
27/05/2016 Incoming Correspondence Paper Response applicant or agent 2 PDF /4/2/1/0/0/0400300124/docs/300124_15_incomingcorrespondencepaper20160527025112421.pdf
26/05/2016 Examination Internal New 2 PDF /4/2/1/0/0/0400300124/docs/300124_2_207097 verzoek correctie expiratiedatum spc300124.pdf
26/05/2016 Examination Internal New 1 PDF /4/2/1/0/0/0400300124/docs/300124_5_300124 publicatieblad eu.pdf
10/09/2003 Outgoing Correspondence Outgoing Letter 1 PDF /4/2/1/0/0/0400300124/docs/300124_4_outgoingcorrespondence20030910.pdf
10/09/2003 Outgoing Correspondence Outgoing Letter 1 PDF /4/2/1/0/0/0400300124/docs/300124_10_outgoingcorrespondence20030910.pdf
03/09/2003 General 1 PDF /4/2/1/0/0/0400300124/docs/300124_6_spc-documents20030903.pdf
02/09/2003 Incoming Correspondence Paper Other 1 PDF /4/2/1/0/0/0400300124/docs/300124_16_incomingcorrespondencepaper20030902.pdf
12/06/2003 Outgoing Correspondence Outgoing Letter 1 PDF /4/2/1/0/0/0400300124/docs/300124_3_outgoingcorrespondence20030612.pdf
23/04/2003 General 4 PDF /4/2/1/0/0/0400300124/docs/300124_0_spc-documents20030423.pdf
23/04/2003 General 19 PDF /4/2/1/0/0/0400300124/docs/300124_1_spc-documents20030423.pdf
23/04/2003 General 2 PDF /4/2/1/0/0/0400300124/docs/300124_7_spc-documents20030423.pdf
23/04/2003 Application Form First filed application form 2 PDF /4/2/1/0/0/0400300124/docs/300124_9_applicationform20030423.pdf
23/04/2003 Application Form First filed application form 27 PDF /4/2/1/0/0/0400300124/docs/300124_13_applicationform20030423.pdf